Getting Smart about Diabetes

At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ensure trials run smoothly and effectively.

An increase in protocol complexity is paving the way for machine learning models to optimize trial design.

The future of clinical trial design involves incorporating the patient experience into strategic asset planning.

Anticipating divestment, reallocation of investments, and retrenchment.